GGrantIndex
Sort

46,585 grants matching heart failure

Discovery and Development of Therapeutic Genes for CHF

$2,917,776
H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2014 · HL

1/2 REPRIEVE Extension for Trial Completion

$2,903,944
Steven Kyle Grinspoon · Massachusetts General Hospital · UG3 · FY2025 · HL

Manufacturable Biomimetic Microfluidic Oxygenator for Safer, Simpler Treatment of Respiratory Failure

$2,899,006
Jeffrey T Borenstein · Biomembretics, Inc. · R42 · FY2025 · HL

IGF::OT::IGF

$2,887,991
James Shikany · University Of Alabama At Birmingham · N01 · FY2015 · HL

HALF-PINT: Heart and Lung Failure - Pediatric INsulin Titration trial - CCC

$2,887,831
Michael Agus · Boston Children'S Hospital · U01 · FY2016 · HL

1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

$2,887,088
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · UH3 · FY2021 · HL

Alabama-Clinical Trials Unit

$2,886,842
Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2008 · AI

Myocardial Ischemia and Transfusion (MINT) - CCC

$2,875,066
Jeffrey Lee Carson · Rbhs-Robert Wood Johnson Medical School · U01 · FY2020 · HL

Control Mechanisms for Matching ATP Supply and Demand in Heart Mitochondria

$2,873,873
Steven Sollott · National Institute On Aging · ZIA · FY2022 · AG

Framingham Project/Levy

$2,869,590
Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

BRIDGE TRIAL

$2,862,492
Thomas L Ortel · Duke University · U01 · FY2014 · HL

Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis

$2,862,143
Brian Lim Hoh · University Of Florida · U01 · FY2024 · NS

Applying Genomics and Omics in Pig to Human Decedent Xenotransplantation

$2,856,183
Adam David Griesemer · New York University School Of Medicine · U19 · FY2025 · AI

CLINICAL EXAMINATION CENTER

$2,854,302
Aaron R Folsom · University Of Minnesota · N01 · FY2012 · HL

Childhood CV Risk and Adult CVD Outcomes: an International Long-term Follow-up

$2,842,453
Jessica G Woo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · HL

Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study

$2,840,000
Harold I Feldman · University Of Pennsylvania · U01 · FY2016 · DK

Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study

$2,840,000
Harold I Feldman · University Of Pennsylvania · U01 · FY2017 · DK

The Genetics of Uveal Coloboma

$2,837,831
Brian Brooks · National Eye Institute · ZIA · FY2018 · EY

PHARMACOGENOMICS OF ARRHYTHMIA THERAPY

$2,836,953
Vanderbilt University · U01 · FY2004 · HL

Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias

$2,829,920
Courtney Joseph · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

HCMR Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

$2,829,326
Christopher M Kramer · University Of Virginia · U01 · FY2016 · HL

Etiology of Geographic and Racial Differences in Stroke

$2,816,745
George Howard · University Of Alabama At Birmingham · U01 · FY2007 · NS

Exploiting accelerated aging associated with Low Earth Orbit (LEO) environment to gain insights into pathogenesis and treatment of progressive neurological disorders

$2,815,841
Palaniappan Sethu · University Of Alabama At Birmingham · UG3 · FY2025 · AG

PHARMACOGENOMICS OF ARRHYTHMIA THERAPY

$2,815,099
Vanderbilt University · U01 · FY2001 · HL

Comparative Effectiveness of Health System vs. Multilevel Interventions to Reduce Hypertension Disparities

$2,814,626
Lisa A Cooper · Johns Hopkins University · UH3 · FY2016 · HL